Northwest Gastroenterology Associates

Bellevue, Washington 98008

0 studies enrolling now · 11 studies all time

What they study most

Chronic Constipation, Chronic Idiopathic Constipation, Colitis, Ulcerative, Colon Cancer, Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, Crohn's Disease, Digestive System Diseases, Irritable Bowel Syndrome, Irritable Bowel Syndrome With Constipation, Opioid-Induced Bowel Dysfunction

Studies at this site

• A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis (UC) Participants Who Are Naive to Tumor Necrosis Factor (TNF) Inhibitors — Completed
• Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone — Completed
• Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone — Completed
• Study to Assess the Efficacy and Safety of Rifaximin Administered BID in the Treatment of Patients With Diarrhea-Associated Irritable Bowel Syndrome — Completed
• An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation — Completed
• Safety and Tolerability Extension Trial for Patients With Chronic Idiopathic Constipation — Completed
• Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer — Completed
• 26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation — Stopped early
• PRESEPT Study: Evaluation of SEPT9 Biomarker Performance for Colorectal Cancer Screening — Completed
• Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease — Completed
• BLI850-302: BLI850 vs an Approved Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy — Completed